Functionalized micellar systems for cancer targeted drug delivery

Damon Sutton, Norased Nasongkla, Elvin Blanco, Jinming Gao

Research output: Contribution to journalArticle

396 Citations (Scopus)

Abstract

Polymer micelles are rapidly becoming a powerful nanomedicine platform for cancer therapeutic applications due to their small size (10-100 nm), in vivo stability, ability to solubilize water insoluble anticancer drugs, and prolonged blood circulation times. Recent data from clinical trials with three micelle formulations have highlighted these and other pharmacokinetic advantages with reduced systemic toxicity and patient morbidity compared to conventional drug formulation. While the initial anti-tumor efficacy of these systems seems promising, a strong research impetus has been placed on micelle functionalization in order to achieve tumor targeting and site-specific drug release, with the hope of reaching a more pronounced tumor response. Hence, the purpose of this review is to draw attention to the new developments of multi-functional polymer micelles for cancer therapy with special focus on tumor targeting and controlled drug release strategies.

Original languageEnglish (US)
Pages (from-to)1029-1046
Number of pages18
JournalPharmaceutical Research
Volume24
Issue number6
DOIs
StatePublished - Jun 2007

Fingerprint

Micelles
Tumors
Pharmaceutical Preparations
Neoplasms
Medical nanotechnology
Functional polymers
Pharmacokinetics
Polymers
Hemodynamics
Blood Circulation Time
Nanomedicine
Toxicity
Drug Compounding
Targeted drug delivery
Water
Clinical Trials
Morbidity
Therapeutics
Research

Keywords

  • Active targeting
  • Cancer nanomedicine
  • Micelle pharmacokinetics
  • Polymer micelles
  • Responsive drug release

ASJC Scopus subject areas

  • Chemistry(all)
  • Pharmaceutical Science
  • Pharmacology

Cite this

Functionalized micellar systems for cancer targeted drug delivery. / Sutton, Damon; Nasongkla, Norased; Blanco, Elvin; Gao, Jinming.

In: Pharmaceutical Research, Vol. 24, No. 6, 06.2007, p. 1029-1046.

Research output: Contribution to journalArticle

Sutton, Damon ; Nasongkla, Norased ; Blanco, Elvin ; Gao, Jinming. / Functionalized micellar systems for cancer targeted drug delivery. In: Pharmaceutical Research. 2007 ; Vol. 24, No. 6. pp. 1029-1046.
@article{460474a217694f609ce267791b08800b,
title = "Functionalized micellar systems for cancer targeted drug delivery",
abstract = "Polymer micelles are rapidly becoming a powerful nanomedicine platform for cancer therapeutic applications due to their small size (10-100 nm), in vivo stability, ability to solubilize water insoluble anticancer drugs, and prolonged blood circulation times. Recent data from clinical trials with three micelle formulations have highlighted these and other pharmacokinetic advantages with reduced systemic toxicity and patient morbidity compared to conventional drug formulation. While the initial anti-tumor efficacy of these systems seems promising, a strong research impetus has been placed on micelle functionalization in order to achieve tumor targeting and site-specific drug release, with the hope of reaching a more pronounced tumor response. Hence, the purpose of this review is to draw attention to the new developments of multi-functional polymer micelles for cancer therapy with special focus on tumor targeting and controlled drug release strategies.",
keywords = "Active targeting, Cancer nanomedicine, Micelle pharmacokinetics, Polymer micelles, Responsive drug release",
author = "Damon Sutton and Norased Nasongkla and Elvin Blanco and Jinming Gao",
year = "2007",
month = "6",
doi = "10.1007/s11095-006-9223-y",
language = "English (US)",
volume = "24",
pages = "1029--1046",
journal = "Pharmaceutical Research",
issn = "0724-8741",
publisher = "Springer New York",
number = "6",

}

TY - JOUR

T1 - Functionalized micellar systems for cancer targeted drug delivery

AU - Sutton, Damon

AU - Nasongkla, Norased

AU - Blanco, Elvin

AU - Gao, Jinming

PY - 2007/6

Y1 - 2007/6

N2 - Polymer micelles are rapidly becoming a powerful nanomedicine platform for cancer therapeutic applications due to their small size (10-100 nm), in vivo stability, ability to solubilize water insoluble anticancer drugs, and prolonged blood circulation times. Recent data from clinical trials with three micelle formulations have highlighted these and other pharmacokinetic advantages with reduced systemic toxicity and patient morbidity compared to conventional drug formulation. While the initial anti-tumor efficacy of these systems seems promising, a strong research impetus has been placed on micelle functionalization in order to achieve tumor targeting and site-specific drug release, with the hope of reaching a more pronounced tumor response. Hence, the purpose of this review is to draw attention to the new developments of multi-functional polymer micelles for cancer therapy with special focus on tumor targeting and controlled drug release strategies.

AB - Polymer micelles are rapidly becoming a powerful nanomedicine platform for cancer therapeutic applications due to their small size (10-100 nm), in vivo stability, ability to solubilize water insoluble anticancer drugs, and prolonged blood circulation times. Recent data from clinical trials with three micelle formulations have highlighted these and other pharmacokinetic advantages with reduced systemic toxicity and patient morbidity compared to conventional drug formulation. While the initial anti-tumor efficacy of these systems seems promising, a strong research impetus has been placed on micelle functionalization in order to achieve tumor targeting and site-specific drug release, with the hope of reaching a more pronounced tumor response. Hence, the purpose of this review is to draw attention to the new developments of multi-functional polymer micelles for cancer therapy with special focus on tumor targeting and controlled drug release strategies.

KW - Active targeting

KW - Cancer nanomedicine

KW - Micelle pharmacokinetics

KW - Polymer micelles

KW - Responsive drug release

UR - http://www.scopus.com/inward/record.url?scp=34249023676&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34249023676&partnerID=8YFLogxK

U2 - 10.1007/s11095-006-9223-y

DO - 10.1007/s11095-006-9223-y

M3 - Article

C2 - 17385025

AN - SCOPUS:34249023676

VL - 24

SP - 1029

EP - 1046

JO - Pharmaceutical Research

JF - Pharmaceutical Research

SN - 0724-8741

IS - 6

ER -